Keywords: Tumors (Pre-Treatment), Brain, Neuro
Motivation: Noninvasive measurement of the MGMT methylation status has great clinical significance for making a tailored treatment plan and prognosis assessment.
Goal(s): This study aimed to establish and validate a radiomics nomogram with robust radiomics features from ADC and ISO-CE-T1-weighted images.
Approach: The radiomics features were selected using LASSO regression. A radiomics nomogram combined radiomics signature and clinical factors were established with multivariate logistic regression analysis.
Results: The radiomics nomogram is a promising method. The Hosmer-Lemeshow test concluded that the radiomics nomogram showed goodness of fit. The decision curve showed that the addition of clinical characteristics to the nomogram showed incremental predictive value.
Impact: The multiparametric MRI-based radiomics nomogram was a promising method to preoperatively predict the MGMT mpromoter ethylation status noninvasively. Besides, the nomogram transformed the prediction signature into a visual and readable graph, making it easier to understand.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords